Women Underwent TRAM Surgery: Its Influence on Abdominal Muscle Function and the Effects of Therapeutic Exercises

Post-mastectomy Women Underwent Transverse Rectus Abdominis Musculocutaneous Flap (TRAM) Surgery: Its Influence on Abdominal Muscle Function and the Effects of Therapeutic Exercises

The unilateral transverse rectus abdominis musculocutaneous (TRAM) flap is a major operation widely used for breast reconstruction. It is hypothesized that this surgery has the potential risk of weakening the abdominal wall because it disrupts the integrity of the rectus abdominis muscle (RA), therefore, alters the insertion of the oblique muscles and the biomechanical relationship between the RA muscle and adjacent structures. The purposes of this study were to examine the effects of the TRAM flap surgery on muscle size of abdominal muscles, strength and endurance of trunk muscles, strength and endurance of core stability, as well as the effects of therapeutic exercises on it in post-mastectomy women underwent TRAM surgery.

Study Overview

Status

Completed

Conditions

Detailed Description

This first year of the proposed study was aimed to understand the impacts on abdominal muscle functions. We design a case-control, cross-sectional study. There were 46 women who have undergone TRAM flap and 36 age-matched healthy women. We recorded the biomechanic and electromyographic responses during voluntary limb movements and elicited by unexpected support surface translations and tilts in standing. A six-camera Qualisys motion system was used. Ground reaction forces and moments were acquired by one Kisler force plate. Surface electromyography electrodes were used to record the activity of selected trunk and limb muscles. The second year was aimed to evaluate the effects on abdominal muscle functions after 12 weeks abdominal muscle training in the TRAM women. Outcome measures were the clinical tests for trunk muscle strength, endurance and one-leg standing was also used to exam the abdominal muscle function.

Study Type

Interventional

Enrollment (Actual)

82

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

30 years to 60 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  1. Healthy adults

    • Their age should be ranged between 30 - 60 years
  2. TRAM flap surgery patients

    • at least 6 months after the MS pedicled TRAM flap surgery

Exclusion Criteria:

  1. Healthy adults

    • a history of injury resulting in an inability to perform activities of daily living
    • scoliosis or spinal surgery
    • neurological, neuromuscular, rheumatological or systemic diseases
  2. TRAM flap surgery patients

    • tumor distant metastasis
    • a history of injury resulting in an inability to perform activities of daily living
    • scoliosis or spinal surgery
    • neurological, neuromuscular, rheumatological or systemic diseases

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: TRAM abdominal muscle training group

Patients were recruited at least 6 months after the muscle-sparing (MS) pedicled Transverse rectus abdominis musculocutaneous (TRAM) flap procedure and at least 1 month after the conclusion of the last chemotherapy course, if any.

All subjects will receive 1-hr training sessions consisting of core stability exercises for 12 weeks for the TRAM group.

Participants will receive 12-week, 60 minutes, 36-session abdominal muscle training in the TRAM women. Aimed to evaluate the effects on abdominal muscle functions after 12 weeks abdominal muscle training in the TRAM women. Outcome measures were the clinical tests for trunk muscle strength, endurance and one-leg standing was also used to exam the abdominal muscle function.
No Intervention: TRAM control group

Patients were recruited at least 6 months after the muscle-sparing (MS) pedicled Transverse rectus abdominis musculocutaneous (TRAM) flap procedure and at least 1 month after the conclusion of the last chemotherapy course, if any.

The control group was not received any exercise program.

No Intervention: Healthy women group
A control group comprising female volunteers who were apparently healthy and had comparable socioeconomic backgrounds and physical conditions was recruited by convenience sampling from communities.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in thickness of abdominal wall muscles at 12-week
Time Frame: The assessments will be conducted 1 and 12 weeks following the intervention
Using the Ultrasound imaging to measure the thickness of all abdominal wall muscles at rest and in an isometric contraction.
The assessments will be conducted 1 and 12 weeks following the intervention
Changes in the cross-sectional area of the rectus abdominis muscle (RA) muscle at 12-week
Time Frame: The assessments will be conducted 1 and 12 weeks following the intervention
Using the Ultrasound imaging to measure the cross-sectional area of the rectus abdominis muscle at rest and in an isometric contraction.
The assessments will be conducted 1 and 12 weeks following the intervention
Changes in strength of the trunk muscles at 12-week
Time Frame: The assessments will be conducted 1 and 12 weeks following the intervention
Using the dynamometer and clinical tests (prone extension, curl-up and rotational curl-up) to measure the trunk strength
The assessments will be conducted 1 and 12 weeks following the intervention
Changes in endurance of the trunk muscles at 12-week
Time Frame: The assessments will be conducted 1 and 12 weeks following the intervention
Using the clinical tests (abdominal muscle test for strength, unsupported double bend leg lifting for static endurance) to measure the endurance of trunk muscles
The assessments will be conducted 1 and 12 weeks following the intervention
Changes in balanced functions at 12-week
Time Frame: The assessments will be conducted 1 and 12 weeks following the intervention
Using the seconds in the following static position to measure the balance: one-leg standing with the other lift-leg 1 inch of ground clearance; single leg standing with the other lift-leg hip flexion 90 degrees and the tibia vertical to the floor.
The assessments will be conducted 1 and 12 weeks following the intervention
Changes in muscle activity of selected trunk and limb muscles at 12-week
Time Frame: The assessments will be conducted 1 and 12 weeks following the intervention
Using A six-camera Qualisys motion system to measure the muscle activity of selected trunk and limb muscles.
The assessments will be conducted 1 and 12 weeks following the intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Li-Jiun Liaw, Kaohsiung Medical University Department of Physical Therapy Associate Professor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 24, 2009

Primary Completion (Actual)

September 8, 2014

Study Completion (Actual)

September 8, 2014

Study Registration Dates

First Submitted

May 11, 2021

First Submitted That Met QC Criteria

May 11, 2021

First Posted (Actual)

May 14, 2021

Study Record Updates

Last Update Posted (Actual)

May 14, 2021

Last Update Submitted That Met QC Criteria

May 11, 2021

Last Verified

February 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • KMUH-IRB-970469

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Currently in the submission stage ,and then share with other researchers after publication

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Breast Neoplasms

Clinical Trials on Abdominal muscle training

3
Subscribe